NEW YORK (Reuters) - Martin Shkreli, the former drug company executive who made headlines by jacking up the price of a lifesaving drug before he was accused and found guilty of defrauding investors, was sentenced to 7 years on Friday.
Shkreli, 34, was sentenced by U.S. District Judge Kiyo Matsumoto in Brooklyn federal court.
(Reporting By Brendan Pierson in New York; Editing by Meredith Mazzilli)
Disclaimer: No Business Standard Journalist was involved in creation of this content
